- Home
- DERM vs FINW Comparison
DERM vs FINW Comparison
Compare DERM & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- FINW
- Stock Information
- Founded
- DERM 2014
- FINW 1999
- Country
- DERM United States
- FINW United States
- Employees
- DERM N/A
- FINW N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- DERM Health Care
- FINW Finance
- Exchange
- DERM Nasdaq
- FINW Nasdaq
- Market Cap
- DERM 181.0M
- FINW 207.1M
- IPO Year
- DERM 2021
- FINW 2021
- Fundamental
- Price
- DERM $7.15
- FINW $15.57
- Analyst Decision
- DERM Strong Buy
- FINW Buy
- Analyst Count
- DERM 1
- FINW 4
- Target Price
- DERM $9.00
- FINW $20.75
- AVG Volume (30 Days)
- DERM 179.1K
- FINW 78.2K
- Earning Date
- DERM 08-11-2025
- FINW 07-24-2025
- Dividend Yield
- DERM N/A
- FINW N/A
- EPS Growth
- DERM N/A
- FINW N/A
- EPS
- DERM N/A
- FINW 0.91
- Revenue
- DERM $56,243,000.00
- FINW $72,056,000.00
- Revenue This Year
- DERM $28.99
- FINW $38.17
- Revenue Next Year
- DERM $52.61
- FINW $18.44
- P/E Ratio
- DERM N/A
- FINW $17.02
- Revenue Growth
- DERM N/A
- FINW 7.66
- 52 Week Low
- DERM $3.54
- FINW $10.32
- 52 Week High
- DERM $8.25
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- DERM 53.22
- FINW 60.72
- Support Level
- DERM $6.78
- FINW $15.23
- Resistance Level
- DERM $7.34
- FINW $16.23
- Average True Range (ATR)
- DERM 0.35
- FINW 0.54
- MACD
- DERM 0.03
- FINW 0.14
- Stochastic Oscillator
- DERM 78.81
- FINW 72.73
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.